Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Riviere, Cynthia"" wg kryterium: Autor


Wyświetlanie 1-9 z 9
Tytuł:
Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from Haiti.
Autorzy:
Dorvil N; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Rivera VR; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Riviere C; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Berman R; The Analysis Group, Boston, Massachusetts, United States of America.
Severe P; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Bang H; University of California, Davis School of Medicine, Davis, California, United States of America.
Lavoile K; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Devieux JG; Florida International University, Miami, Florida, United States of America.
Faustin M; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Saintyl G; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Mendicuti MD; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Pierre S; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Apollon A; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Dumond E; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Forestal GPL; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Rouzier V; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.; Weill Cornell Medicine, New York, New York, United States of America.
Marcelin A; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
McNairy ML; Weill Cornell Medicine, New York, New York, United States of America.
Walsh KF; Weill Cornell Medicine, New York, New York, United States of America.
Dupnik K; Weill Cornell Medicine, New York, New York, United States of America.
Reif LK; Weill Cornell Medicine, New York, New York, United States of America.
Byrne AL; St. Vincent's Hospital, Darlinghurst, New South Wales, Australia.
Bousleiman S; The Analysis Group, Boston, Massachusetts, United States of America.
Orvis E; The Analysis Group, Boston, Massachusetts, United States of America.
Joseph P; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Cremieux PY; The Analysis Group, Boston, Massachusetts, United States of America.
Pape JW; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.; Weill Cornell Medicine, New York, New York, United States of America.
Koenig SP; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2023 Jun 09; Vol. 20 (6), pp. e1004246. Date of Electronic Publication: 2023 Jun 09 (Print Publication: 2023).
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Anti-HIV Agents*/therapeutic use
HIV Infections*/complications
HIV Infections*/diagnosis
HIV Infections*/drug therapy
Tuberculosis*/complications
Tuberculosis*/diagnosis
Tuberculosis*/drug therapy
Adult ; Humans ; Haiti/epidemiology ; RNA
Czasopismo naukowe
Tytuł:
Success of community approach to HPV vaccination in school-based and non-school-based settings in Haiti.
Autorzy:
Riviere C; GHESKIO Center, Port-au-Prince, Haiti.
Bell T; GHESKIO Center, Port-au-Prince, Haiti.
Cadot Y; GHESKIO Center, Port-au-Prince, Haiti.
Perodin C; GHESKIO Center, Port-au-Prince, Haiti.
Charles B; GHESKIO Center, Port-au-Prince, Haiti.
Bertil C; GHESKIO Center, Port-au-Prince, Haiti.
Cheung J; Analysis Group, Inc., Boston, Massachusetts, United States of America.
Bane S; Analysis Group, Inc., Boston, Massachusetts, United States of America.
Cheung HC; Analysis Group, Inc., Boston, Massachusetts, United States of America.
Pape JW; GHESKIO Center, Port-au-Prince, Haiti.; Center for Global Health, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America.
Deschamps MM; GHESKIO Center, Port-au-Prince, Haiti.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Jun 24; Vol. 16 (6), pp. e0252310. Date of Electronic Publication: 2021 Jun 24 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Patient Acceptance of Health Care*
Immunization Programs/*methods
Papillomaviridae/*drug effects
Papillomavirus Infections/*prevention & control
Papillomavirus Vaccines/*administration & dosage
Schools/*statistics & numerical data
Vaccination/*statistics & numerical data
Adolescent ; Adult ; Aged ; Child ; Community Health Services ; Female ; Haiti/epidemiology ; Health Knowledge, Attitudes, Practice ; Humans ; Male ; Middle Aged ; Papillomaviridae/immunology ; Papillomavirus Infections/epidemiology ; Papillomavirus Infections/virology ; Young Adult
Czasopismo naukowe
Tytuł:
Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study.
Autorzy:
Shivakoti R; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .; Present Address: Department of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th St, Room 705, New York, NY, 10032, USA. .
Gupte N; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Tripathy S; National AIDS Research Institute, Pune, India.; Present Address: National Institute of Research in Tuberculosis, Chennai, India.
Poongulali S; YR Gaitonde Center for AIDS Research and Education, Chennai, India.
Kanyama C; UNC Lilongwe, Lilongwe, Malawi.
Berendes S; Malawi College of Medicine-Johns Hopkins University Research Project, Blantyre, Malawi.; Present Address: Liverpool School of Tropical Medicine, Liverpool, UK.
Cardoso SW; STD/AIDS Clinical Research Laboratory, Instituto de Pesquisa Clinica Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
Santos BR; Hospital Nossa Senhora de Conceiçã, Porto Alegre, Brazil.
La Rosa A; Asociacion Civil Impacta Salud y Educacion, Lima, Peru.
Mwelase N; Department of Medicine, University of Witwatersrand, Johannesburg, South Africa.
Pillay S; Durban International Clinical Research Site, Durban University of Technology, Durban, South Africa.
Samaneka W; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.
Riviere C; Les Centres GHESKIO, Port-Au-Prince, Haiti.
Sugandhavesa P; Research Institute for Health Sciences, Chiang Mai, Thailand.
Bollinger RC; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Balagopal A; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Semba RD; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Christian P; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Present Address: Bill and Melinda Gates Foundation, Seattle, USA.
Campbell TB; Department of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO, USA.
Gupta A; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pokaż więcej
Corporate Authors:
NWCS 319 and PEARLS Study Team
Źródło:
BMC medicine [BMC Med] 2018 Sep 24; Vol. 16 (1), pp. 161. Date of Electronic Publication: 2018 Sep 24.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/blood
HIV Infections*/complications
HIV Infections*/drug therapy
Biomarkers/*blood
Inflammation/*blood
Micronutrients/*blood
Tuberculosis/*complications
Adult ; Anti-HIV Agents/therapeutic use ; Antiretroviral Therapy, Highly Active/methods ; Case-Control Studies ; Female ; Humans ; Male ; Middle Aged ; Proportional Hazards Models ; Trace Elements/blood ; Treatment Failure ; Tuberculosis/drug therapy ; Young Adult
Czasopismo naukowe
Tytuł:
Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial.
Autorzy:
Koenig SP; Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Dorvil N; Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Dévieux JG; AIDS Prevention Program, Florida International University, Miami, Florida, United States of America.
Hedt-Gauthier BL; Department of Global Health and Social Medicine, Harvard Medical School, Harvard University, Boston, Massachusetts, United States of America.
Riviere C; Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Faustin M; Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Lavoile K; Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Perodin C; Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Apollon A; Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Duverger L; Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
McNairy ML; Center for Global Health, Department of Medicine, Weill Cornell Medical College, Cornell University, New York, New York, United States of America.; Division of General Internal Medicine, Department of Medicine, Weill Cornell Medical College, Cornell University, New York, New York, United States of America.
Hennessey KA; Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Souroutzidis A; Analysis Group, Boston, Massachusetts, United States of America.
Cremieux PY; Analysis Group, Boston, Massachusetts, United States of America.
Severe P; Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Pape JW; Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.; Center for Global Health, Department of Medicine, Weill Cornell Medical College, Cornell University, New York, New York, United States of America.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2017 Jul 25; Vol. 14 (7), pp. e1002357. Date of Electronic Publication: 2017 Jul 25 (Print Publication: 2017).
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Anti-HIV Agents/*therapeutic use
Communicable Disease Control/*methods
HIV Infections/*diagnosis
HIV Infections/*drug therapy
Adult ; Female ; Haiti ; Humans ; Male ; Middle Aged ; Time Factors
Czasopismo naukowe
Tytuł:
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.
Autorzy:
Tenforde MW; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Gupte N; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Dowdy DW; Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Asmuth DM; University of California Davis Medical Center, Sacramento, California, United States of America.
Balagopal A; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Pollard RB; University of California Davis Medical Center, Sacramento, California, United States of America.
Sugandhavesa P; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Lama JR; Asociación Civil Impacta Salud y Educación (IMPACTA) Peru Clinical Trials Unit, Lima, Peru.
Pillay S; Nelson Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Cardoso SW; Instituto de Pesquisa Clínica Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Pawar J; National AIDS Research Institute, Pune, India.
Santos B; Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil.
Riviere C; Les Centres Groupe Haïtien d'Etude du Sarcome de Kaposi et des Infections Opportunites (GHESKIO), Port-Au-Prince, Haiti.
Mwelase N; University of Witwatersrand, Johannesburg, South Africa.
Kanyama C; University of North Carolina Project, Kamuzu Central Hospital, Lilongwe, Malawi.
Kumwenda J; Malawi College of Medicine-Johns Hopkins University Research Project, Blantyre, Malawi.
Hakim JG; University of Zimbabwe, Harare, Zimbabwe.
Kumarasamy N; Y.R. Gaitonde Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Bollinger R; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Semba RD; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Campbell TB; University of Colorado Denver School of Medicine, Aurora, Colorado, United States of America.
Gupta A; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Pokaż więcej
Corporate Authors:
ACTG PEARLS and NWCS 319 Study Group
Źródło:
PloS one [PLoS One] 2015 Feb 26; Vol. 10 (2), pp. e0117424. Date of Electronic Publication: 2015 Feb 26 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
AIDS-Related Opportunistic Infections/*blood
Anti-Retroviral Agents/*adverse effects
C-Reactive Protein/*metabolism
Chemokine CXCL10/*blood
Lipopolysaccharides/*blood
Tuberculosis/*blood
AIDS-Related Opportunistic Infections/epidemiology ; Adult ; Developing Countries ; Female ; Humans ; Incidence ; Male ; Risk ; Tuberculosis/epidemiology
Czasopismo naukowe
Tytuł:
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.
Autorzy:
Campbell TB; Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Aurora, United States of America. />Smeaton LM
Kumarasamy N
Flanigan T
Klingman KL
Firnhaber C
Grinsztejn B
Hosseinipour MC
Kumwenda J
Lalloo U
Riviere C
Sanchez J
Melo M
Supparatpinyo K
Tripathy S
Martinez AI
Nair A
Walawander A
Moran L
Chen Y
Snowden W
Rooney JF
Uy J
Schooley RT
De Gruttola V
Hakim JG
Pokaż więcej
Corporate Authors:
PEARLS study team of the ACTG
Źródło:
PLoS medicine [PLoS Med] 2012; Vol. 9 (8), pp. e1001290. Date of Electronic Publication: 2012 Aug 14.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Internationality*
Anti-HIV Agents/*adverse effects
Anti-HIV Agents/*therapeutic use
Antiretroviral Therapy, Highly Active/*adverse effects
HIV Infections/*drug therapy
HIV Infections/*virology
HIV-1/*drug effects
Anti-HIV Agents/pharmacology ; Coinfection ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; HIV Infections/microbiology ; Humans ; Male ; Mycobacterium tuberculosis/physiology ; Pregnancy ; Time Factors ; Treatment Outcome ; Withholding Treatment
Czasopismo naukowe
Tytuł:
Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti.
Autorzy:
Koenig SP; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Bang H
Severe P
Jean Juste MA
Ambroise A
Edwards A
Hippolyte J
Fitzgerald DW
McGreevy J
Riviere C
Marcelin S
Secours R
Johnson WD
Pape JW
Schackman BR
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2011 Sep; Vol. 8 (9), pp. e1001095. Date of Electronic Publication: 2011 Sep 20.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Health Care Costs*
Anti-Retroviral Agents/*economics
Delivery of Health Care/*economics
HIV Infections/*drug therapy
Standard of Care/*economics
Adult ; Anti-Retroviral Agents/administration & dosage ; Anti-Retroviral Agents/adverse effects ; CD4 Lymphocyte Count ; Cost-Benefit Analysis ; Delivery of Health Care/standards ; Drug Administration Schedule ; Female ; Guidelines as Topic ; HIV Infections/economics ; Haiti ; Humans ; Life Expectancy ; Male
Czasopismo naukowe
Tytuł:
Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals.
Autorzy:
Charles M; Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes, Port-au-Prince, Haiti.
Noel F
Leger P
Severe P
Riviere C
Beauharnais CA
Miller E
Rutledge J
Bang H
Shealey W
D'Aquila RT
Gulick RM
Johnson WD Jr
Wright PF
Pape JW
Fitzgerald DW
Pokaż więcej
Źródło:
Bulletin of the World Health Organization [Bull World Health Organ] 2008 Dec; Vol. 86 (12), pp. 970-7.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-HIV Agents/*therapeutic use
Drug Resistance, Multiple, Viral/*genetics
HIV Infections/*epidemiology
HIV-1/*genetics
RNA/*genetics
Adolescent ; Adult ; Drug Resistance, Multiple, Viral/drug effects ; Female ; HIV Infections/blood ; HIV Infections/drug therapy ; HIV Infections/mortality ; Haiti/epidemiology ; Humans ; Male ; Prospective Studies ; Surveys and Questionnaires ; Survival Analysis ; Young Adult
Czasopismo naukowe
Tytuł:
The cost of antiretroviral therapy in Haiti.
Autorzy:
Koenig SP; Division of Social Medicine and Health Inequalities, Brigham and Women's Hospital, Boston, MA 02115, USA. />Riviere C
Leger P
Severe P
Atwood S
Fitzgerald DW
Pape JW
Schackman BR
Pokaż więcej
Źródło:
Cost effectiveness and resource allocation : C/E [Cost Eff Resour Alloc] 2008 Feb 14; Vol. 6, pp. 3. Date of Electronic Publication: 2008 Feb 14.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-9 z 9

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies